Creating a new platform to quickly test protein variations for useful applications
Development of a high throughput platform for screening directed evolution libraries
This study is working on a new way to quickly create and test lots of different proteins to find ones that could lead to better treatments or products, which might help patients in the future.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Santa Cruz NIH-funded |
| Lab location | 1 site (Santa Cruz, United States) |
| Project ID | NIH-10990473 on NIH RePORTER |
What this research studies
This research focuses on developing a high throughput platform that enhances the process of directed evolution, which is a method used to create proteins with specific desired traits. By generating and screening thousands of protein variants efficiently, the research aims to overcome current limitations in identifying valuable biochemical products. The approach involves using advanced analytical techniques like high performance liquid chromatography and mass spectrometry to evaluate the effectiveness of these protein variants. Patients may benefit indirectly through the development of new therapies or industrial applications derived from these proteins.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that could be treated with novel proteins or therapies developed through this technology.
Not a fit: Patients with conditions that do not involve protein-based therapies or those not related to the biochemical applications of this research may not receive any benefit.
Why it matters
Potential benefit: If successful, this research could lead to the creation of new and more effective therapies or products that improve patient care and treatment options.
How similar studies have performed: Other research has shown success with high throughput screening methods in protein engineering, indicating that this approach has potential for significant advancements.
Where this research is happening
Santa Cruz, United States
- University of California Santa Cruz — Santa Cruz, United States (Active)
Researchers
- Principal investigator: Sanchez, Laura Margaret — University of California Santa Cruz
- Study coordinator: Sanchez, Laura Margaret
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.